Mapp Biopharmaceutical, Incorporated Contract Details

Defense contract under the Defense Threat Reduction Agency awarded to Mapp Biopharmaceutical, Incorporated on 6/12/2014.

Per the U.S. DoD, * Indicates a "small business" classification and ** indicates a "small disadvantaged business". NOTE: the U.S. DoD only publicly reports contracts valued at $6.5 million USD or greater.

The contract language is EXACTLY as it appears on the official U.S. DoD website ( unless otherwise noted.

Contractor: Mapp Biopharmaceutical, Incorporated
Department: Defense Threat Reduction Agency
Awarded: 6/12/2014

Mapp Biopharmaceutical, Inc, San Diego, California, is being awarded an $8,152,103 cost- plus-fixed-fee contract for the development of a broad-spectrum monoclonal cocktail for prevention of VEEV, WEEV and EEEV, in support of the research and development enterprise. Work will be performed in San Diego, California, and various subcontractor locations; work is expected to be completed May 2017. Bids were solicited and nine were received. The contracting activity is Defense Threat Reduction Agency, Fort Belvoir, Virginia (HDTRA1-14-C-0115).

Total Contract Value: $8,152,103

View all contracts that include "Mapp Biopharmaceutical, Incorporated" in the MiC database.